Massimo Derenzini

Suggest Changes
Learn More
BACKGROUND Triple-negative breast cancer (TNBC) is an aggressive disease, nevertheless exhibiting a high response rate to chemotherapy. Since the retinoblastoma protein (pRb) loss confers a high(More)